Development and validation of a SARS-CoV-2 variant surrogate Viral Neutralization Test (sVNT)

Project Details

Acronym Antibody-CoV-ID
StatusFinished
Effective start/end date8/12/22 → 30/04/23

Funding

  • European Commission: €50,000.00